Skip to main content
. 2017 Jul 21;16(4):4038–4044. doi: 10.3892/mmr.2017.7063

Table I.

Top 30 most significant DEGs in breast cancer samples with poor prognosis compared with those with good prognosis.

Gene P-value LogFC Gene P-value LogFC
CHRDL2 5.74E-05 −2.95172 CSH1 0.003025 1.197913
ERP27 0.000228 −1.67607 CPT1A 0.003214 1.239627
PRSS21 0.000235 −1.98312 LOC105370832 0.003264 −1.71612
LOC100129447 0.000542 −3.5659 IBSP 0.003517 1.247671
TRIM37 0.001246 1.758675 TMEM185B 0.00362 1.212002
TTF2 0.001416 1.823105 PPM1D 0.003634 1.3262
ANKRD60 0.001461 −2.87722 PDP1 0.003666 2.083321
HMGB3 0.001635 1.915918 CDC45 0.003698 2.059617
NBR1 0.001681 −1.71848 NEB 0.003822 1.118614
FKBP1B 0.001731 1.198828 PDE1B 0.003835 −1.64844
MGC16275 0.002375 1.402384 ZNF264 0.004253 −1.65155
C9orf64 0.0025 1.277235 GTSE1 0.004292 1.209348
OPRK1 0.002525 1.891967 HIST1H3B 0.004466 1.522681
LGI4 0.002658 −1.67571 EMX2 0.004667 −1.25036
HIST1H2BE 0.002916 1.817212 FAM9C 0.004707 1.524613

DEGs, differentially expressed genes; FC, fold-change.